Loading stock data…
MTVA
$1.74-0.27 (-13.43%)
Market ClosedLast close Jun 12
MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
MetaVia Inc. in the Healthcare sector is trading at $1.74 with a market capitalization of $14M. Wall Street consensus targets $19.33 (3 analysts), implying a +1011.1% move over the next 12 months. The stock is currently near its 52-week low of $0.97, remaining 68.4% below its 200-day moving average. On fundamentals, Piotroski 1/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 18 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Sell-side targets imply +1011.1% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 18) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$4.03M↓ | -$2.05M↑ | -$3.48M↑ | -$4.30M↓ | -$3.89M |
| Net Income | -$3.82M↓ | -$1.93M↑ | -$3.38M↑ | -$4.00M↓ | -$3.67M |
Peer Comparison
JNJUNHPFE
Fundamentals
MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. The company develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standa...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$13.84M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-144.66%
Volume
Today's trading volume
577,993
Recent News
Sector Update: Healthcare Stocks Gain Late Afternoon
Healthcare stocks rose late Tuesday afternoon, with the NYSE Healthcare Index and the State Street H
Sector Update: Healthcare Stocks Rise Tuesday Afternoon
Healthcare stocks rose Tuesday afternoon, with the NYSE Healthcare Index adding 1.1% and the State S
We're Keeping An Eye On MetaVia's (NASDAQ:MTVA) Cash Burn Rate
Just because a business does not make any money, does not mean that the stock will go down. For example, although...